Showing results (351-360 of 371) with videos related to
Sort By:
Pageof 38
American Journal of Medical Genetics. Part A|November 10, 2020
Phenotypic features in MECP2 duplication syndrome: Effects of ageSarika U Peters, Cary Fu, Eric D Marsh, et al.Journal of Developmental and Behavioral Pediatrics : JDBP|August 24, 2010
A neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlationsJennifer K Gentile, Wen-Hann Tan, Lucia T Horowitz, et al.Transplantation|August 15, 1997
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study GroupA D Mayer, J Dmitrewski, J P Squifflet, et al.Annals of Neurology|January 22, 2021
Multisite Study of Evoked Potentials in Rett SyndromeJoni N Saby, Timothy A Benke, Sarika U Peters, et al.Clinical Genetics|February 22, 2019
Characterizing the phenotypic effect of Xq28 duplication size in MECP2 duplication syndromeSarika U Peters, Cary Fu, Bernhard Suter, et al.British Journal of Cancer|June 23, 2012
Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO studyF M Shebl, L C Sakoda, A Black, et al.Brain Communications|August 17, 2022
Electrophysiological biomarkers of brain function in CDKL5 deficiency disorderJoni N Saby, Patrick J Mulcahey, Alexis E Zavez, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2019
Meeting report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancerM J Gunter, S Alhomoud, M Arnold, et al.American Journal of Medical Genetics. Part A|October 18, 2011
A therapeutic trial of pro-methylation dietary supplements in Angelman syndromeLynne M Bird, Wen-Hann Tan, Carlos A Bacino, et al.ESMO Open|June 13, 2025
Safety overview and management of inavolisib alone and in combination therapies in PIK3CA-mutated, HR-positive, HER2-negative advanced breast cancer (GO39374)V Gambardella, M K Accordino, P L Bedard, et al.Pageof 38